Clinical trials: Gastritis
Acute Gastritis, Chronic Gastritis
A Study to Evaluate the Efficacy and Safety of AD-203
This is a multicenter, active-controlled , randomized, double-blinded, paralleled group clinical study to evaluate the efficacy and safety of AD-203 to demonstrate the non-inferiority of AD-203 compared with Mucosta tab.
- Trial name
- NCT04066530
- Testing
- AD-203, Mucosta tab.
- Where
- South Korea
- Volunteers
- 475 people
- Sponsor
- Addpharma Inc.
Acute Gastritis, Chronic Gastritis
A Study to Evaluate the Safety and Efficacy of DA9601 for Acute and Chronic Gastritis and to Determine the Optimal Clinical Dosage and Administration
This is a multicenter, placebo-controlled, randomized, double-blinded, paralleled group clinical study to evaluate the efficacy of 2-week treatment with DA-9601 tab in patients with acute or chronic gastritis.
- Trial name
- NCT07139886
- Testing
- Stillen® Tab
- Where
- South Korea
- Volunteers
- 212 people
- Sponsor
- Dong-A ST Co., Ltd.
Acute Gastritis, Chronic Gastritis
Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients
The purpose of this study is evaluate the Efficacy and Safety of EUPASIDIN-S Tab. in Gastritis Patients.
- Trial name
- NCT02356679
- Testing
- Eupasidin-s Tab, Stillen Tab.
- Where
- 10 sites in South Korea
- Volunteers
- 230 people
- Sponsor
- Chong Kun Dang Pharmaceutical
Functional Dyspepsia
Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia
The study is conducted in patients with functional dyspepsia or chronic gastritis. The purpose of this study is to: assess whether the dose of Itopride Hydrochloride 150 mg extended release tablets, taken once daily has a similar…
- Trial name
- NCT06217393
- Testing
- Itopride Hydrochloride 150 mg extended release tablets, Itopride Hydrochloride 50 mg film coated tablets
- Where
- 19 sites in Armenia, Malaysia and 3 more
- Volunteers
- 564 people
- Sponsor
- Abbott
Acute Gastritis, Chronic Gastritis
A Study to Evaluate the Efficacy and Safety of DA-5204
This is a multicenter, active-controlled, randomized, double-blinded, paralleled group clinical study to evaluate the efficacy and safety of DA-5204 and to demonstrate the non-inferiority of DA-5204 compared with Stillen® tab.
- Trial name
- NCT02282670
- Testing
- DA-5204, Stillen tab.
- Where
- South Korea
- Volunteers
- 434 people
- Sponsor
- Dong-A ST Co., Ltd.
Chronic Atrophic Gastritis (CAG)
To Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis (CAG)
The purpose of this study is to determine whether Gastropyloric Complex Capsules are safe and effective in the treatment of chronic atrophic gastritis (CAG).
- Trial name
- NCT01474044
- Testing
- Gastropylor Complex Capsules
- Where
- China
- Volunteers
- 851 people
- Sponsor
- Xinjiang Biochemical Pharmaceutical Co., Ltd.
Chronic Gastritis Caused by Helicobacter Pylori
Effect of Chicken Egg Antibody (IgY) on Patients With Chronic Gastritis
H. pylori positive patient volunteers that passed the selection criteria are recruited and divided into a test and a control group.
- Trial name
- NCT02721355
- Testing
- GastimunHP
- Where
- Vietnam
- Volunteers
- 84 people, healthy volunteers welcome
- Sponsor
- Immunology Research Institute in Gifu
Acute Gastritis, Chronic Gastritis
A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.
This is a multicenter, active-controlled, randomized, double-blinded, paralleled group clinical study to evaluate the efficacy of 4-week treatment with Stillen tab. in patients with acute or chronic gastritis.
- Trial name
- NCT01817556
- Testing
- Stillen Tab., Mucosta Tab.
- Where
- South Korea
- Volunteers
- 258 people
- Sponsor
- Dong-A ST Co., Ltd.
Eosinophilic Gastritis, Eosinophilic Gastroenteritis
Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)
This is a 3-part study. Part A is randomized, double-blinded, placebo-controlled and includes patients with eosinophilic gastritis and/or duodenal-only disease.
- Trial name
- HUDSON GI (NCT05251909)
- Testing
- Benralizumab
- Where
- 20 sites in United States, Brazil and 7 more
- Volunteers
- 12 people
- Sponsor
- AstraZeneca
Eosinophilic Gastritis, Eosinophilic Duodenitis
A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, tolerability, and pharmacodynamic effect of subcutaneous lirentelimab (AK002), given monthly for 6 doses, in…
- Trial name
- ENIGMA-SC (NCT05152563)
- Testing
- AK002
- Where
- 76 sites in United States
- Sponsor
- Allakos Inc.
Gastritis
A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495
To Evaluate the Efficacy and Safety of CKD-495
- Trial name
- NCT04255589
- Testing
- CKD-495 75mg, Artemisia Herb 95% Ethanol Soft Ext.(20→1) 60mg
- Where
- 17 sites in South Korea
- Volunteers
- 242 people
- Sponsor
- Chong Kun Dang Pharmaceutical
Gastritis, Acute Gastritis
Phase 4 Study of Sto M Tab. in Acute or Chronic Gastritis
This Phase 4, multicenter, randomized, double-blind, active-controlled, non-inferiority study aims to evaluate the non-inferiority of Stoem Tab. compared to Stillen Tab.
- Conditions
- Gastritis, Acute Gastritis, Chronic Gastritis
- Trial name
- NCT07631065
- Testing
- Stillen Tab., Sto M Tab.
- Volunteers
- 470 people
- Sponsor
- Mather's Pharm. Co., Ltd.
Acute Gastritis, Chronic Gastritis
A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034
This is a multicenter, double-blinded, double-dummy, active-controlled, randomized, Phase III clinical trial to evaluate the efficacy and safety of DA-6034 and to demonstrate the non-inferiority of DA-6034 compared with…
- Trial name
- NCT01813812
- Testing
- DA-6034, Rebamipide 300mg
- Where
- South Korea
- Volunteers
- 492 people
- Sponsor
- Dong-A Pharmaceutical Co., Ltd.
Erosive Gastritis, Erosive Esophagitis(EE)
Bioequivalence Study to Compare Vonoprazan 20 mg Film Coated Tablets Versus Voquezna® 20 mg (Vonoprazan) Tablets
Randomized, Single Dose, Two-Way Crossover, Open Label bioequivalence study to compare Vonoprazan 20 mg Film Coated Tablets versus Voquezna® 20 mg (Vonoprazan) Tablets an oral administration to healthy adults under fasting…
- Conditions
- Erosive Gastritis, Erosive Esophagitis(EE), HELICOBACTER PYLORI INFECTIONS
- Trial name
- NCT07278349
- Testing
- Vonoprazan Tablets, VOQUEZNA® Tablets
- Where
- Jordan
- Volunteers
- 28 people, healthy volunteers welcome
- Sponsor
- Humanis Saglık Anonim Sirketi
Gastritis
Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet
To Evaluate the Efficacy and Safety of CKD-495
- Trial name
- NCT03437785
- Testing
- CKD-495 75mg, CKD-495 150mg, Artemisiae argyi folium 95% ethanol ext.(20→1) 60mg
- Where
- 16 sites in South Korea
- Volunteers
- 250 people
- Sponsor
- Chong Kun Dang Pharmaceutical